Aura Biosciences
Aura Biosciences is a clinical-stage biotechnology company focused on developing precision oncology therapies. Leveraging its proprietary virus-like drug conjugate (VDC) technology platform, Aura Biosciences aims to transform the treatment of cancers with high unmet medical needs. The company’s lead candidate targets ocular and other solid tumors, utilizing targeted delivery to maximize efficacy while minimizing systemic toxicity. Aura Biosciences is committed to advancing innovative cancer therapeutics through rigorous research and clinical development. By harnessing novel biological approaches, the company strives to improve patient outcomes and address significant gaps in current oncology treatment options.
